Strategic partnerships There is a history of collaborations with Butterfly Network and Clarius Mobile Health, indicating a proven pathway to integrate ThinkSono AI training and guidance into established ultrasound ecosystems. Target co-selling with current partners to expand reach in handheld ultrasound markets and distributor networks.

Regulatory momentum ThinkSono has achieved Breakthrough Device Designation from the FDA and is recognized in industry outlets for advancing point-of-care ultrasound with AI guidance. This regulatory traction can be leveraged to accelerate conversations with hospital systems and procurement teams seeking innovative, approved imaging solutions.

Clinical focus The core solution targets non-ultrasound trained clinicians for DVT detection at the point of care, addressing a large market need for rapid, reliable imaging in diverse care settings. Upsell opportunities exist with training programs, deployment in EDs and primary care, and expansion to other AI-guided studies.

Financing signals Recent seed financing rounds and ongoing funding indicate investor confidence and potential for partnerships or co-investment in large-scale pilots. Engage potential customers with proof of funding-backed deployments and joint funding options for broad-scale adoption.

Vertical expansion Current integrations with AI training for DVT and collaborations across major handheld platforms suggest expansion into adjacent indications and imaging workflows. Propose pilots that bundle ThinkSono AI with partner devices to create turnkey, multi-vendor solutions for hospital networks.